& Montero, P
B., Herrmann, A
Two prominent contenders in recent years have been Semaglutide, an FDA-approved medication, and BPC-157, a peptide currently under investigation
Journal of pharmaceutical and biomedical analysis, 2008, 47(3): 596- 602
Many comorbidities of depression are associated with changes of carnitine levels
market, as a safe and highly effective non-opioid, non-NSAID oral therapy initially for the treatment of acute pain and, subsequently, chronic pain." Beyond the MAX-001 platform, the company is committed to applying its intellectual property and unique expertise in neuroscience, drug development, drug formulation and delivery technology, and clinical trial design and pharmacology to develop additional patient-centric therapies that are safe and effective options to advance care and address unmet medical needs